Squarepoint Ops LLC Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Squarepoint Ops LLC increased its stake in Teleflex Incorporated (NYSE:TFX) by 3,029.5% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 39,870 shares of the medical technology company’s stock after buying an additional 38,596 shares during the period. Squarepoint Ops LLC owned 0.08% of Teleflex worth $8,386,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Teleflex by 1.8% in the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after acquiring an additional 96,711 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Teleflex by 12.0% in the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after purchasing an additional 581,312 shares during the last quarter. Wellington Management Group LLP boosted its stake in Teleflex by 2.1% in the 4th quarter. Wellington Management Group LLP now owns 2,496,566 shares of the medical technology company’s stock worth $622,494,000 after purchasing an additional 52,533 shares in the last quarter. Cooke & Bieler LP grew its position in Teleflex by 23.3% during the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after purchasing an additional 172,335 shares during the last quarter. Finally, TD Asset Management Inc increased its stake in Teleflex by 12.0% during the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock valued at $95,928,000 after purchasing an additional 48,832 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Insider Activity

In related news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 1.43% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Truist Financial increased their price target on shares of Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a report on Monday, August 5th. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $205.00 to $245.00 in a report on Monday, July 1st. Stephens boosted their price target on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Finally, Royal Bank of Canada increased their price objective on Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $265.57.

Teleflex Stock Up 0.8 %

Teleflex stock opened at $246.83 on Friday. The stock has a market cap of $11.63 billion, a PE ratio of 39.62, a price-to-earnings-growth ratio of 2.23 and a beta of 1.16. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58. The stock has a fifty day moving average of $237.48 and a 200 day moving average of $221.22. Teleflex Incorporated has a one year low of $177.63 and a one year high of $257.85.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $3.33 by $0.09. The firm had revenue of $749.70 million for the quarter, compared to analysts’ expectations of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.41 EPS. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.97 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio is presently 21.83%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.